Clinical Trial Update: Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating electronic cigarettes as a harm reduction strategy in individuals with substance use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Substance Use Disorder

Snippet

Sponsor: NYU Langone Health | Conditions: Cigarette Smoking, Addiction | Phase 2 | Status: COMPLETED